Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: Systematic review and metaanalysis

Chest

Volumn 136, Issue 4, 2009, Pages 974-982

  Jiménez, David ^a   Uresandi, Fernando ^b   Otero, Remedios ^c   Lobo, José Luis ^d   Monreal, Manuel ^e   Martí, David ^a   Zamora, Javier ^a   Muriel, Alfonso ^a   Aujesky, Drahomir ^f   Yusen, Roger D ^g  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL TXAGORRITXU   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

ARTICLE; DEATH; HIGH RISK PATIENT; HUMAN; INCIDENCE; LUNG EMBOLISM; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 70049084382     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0608     Document Type: Article

References (43)

1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353:1386-1389 (Pubitemid 29192409)
2. Becattini C, Agnelli G. Risk factors for adverse short-term outcome in patients with pulmonary embolism. Thromb Res 2001; 239-244 (Pubitemid 32900559)
3. Büller H, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2004; 126(suppl): 401S-428S
4. Yalamanchili K, Sukhija R, Aronow WS, et al. Prevalence of increased cardiac troponin I levels in patients with and without acute pulmonary embolism and relation of increased cardiac troponin I levels with in-hospital mortality in patients with acute pulmonary embolism. Am J Cardiol 2004; 93:263-264 (Pubitemid 38058749)
5. Konstantinides S. Pulmonary embolism: impact of right ventricular dysfunction. Curr Opin Cardiol 2005; 20:496-501 (Pubitemid 41565332)
6. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106:1263-1268 (Pubitemid 34988646)
7. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102:211-217 (Pubitemid 30451779)
8. Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ 2003; 326:312-313 (Pubitemid 36205164)
9. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism. Circulation 2007; 116:427-433
10. Jiménez D, Díaz G, Molina J, et al. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J 2008; 31:847-853
11. Gallotta G, Palmieri V, Piedimonte V, et al. Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with submassive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information. Int J Cardiol 2008; 124:351-357 (Pubitemid 351305384)
12. Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med 2007; 33:286-292 (Pubitemid 46221234)
13. Wilczynski NL, Haynes RB; Hedges Team. Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey. BMC Med 2004; 2:23
14. Wilczynski NL, Haynes RB. Optimal search strategies for detecting clinically sound prognostic studies in EMBASE: an analytic survey. J Am Med Inform Assoc 2005; 12:481-485 (Pubitemid 40922909)
15. Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology 1993; 4:295-302
16. Blair A, Burg J, Foran J, et al. Guidelines for application of meta-analysis in environmental epidemiology. Regul Toxicol Pharmacol 1995; 22:189-197
17. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of healthcare interventions. J Epidemiol Community Health 1998; 52:377-384 (Pubitemid 28438523)
18. Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006; 144:427-437 (Pubitemid 46768164)
19. StataCorp. Statistical software, version 6, 2000. College Station, TX: Stata Corp, 2000
20. Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6:31 (Pubitemid 44285240)
21. Hsu JT, Chu CM, Chang ST, et al. Prognostic role of right ventricular dilatation and troponin I elevation in acute pulmonary embolism. Int Heart J 2006; 47:775-781
22. Zhu L, Yang YH, Wu YF, et al. Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary embolism. Chin Med J (Engl) 2007; 120:17-21 (Pubitemid 46117578)
23. Kucher N, Wallman D, Carone A, et al. Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism. Eur Heart J 2003; 24:1651-1656 (Pubitemid 37174904)
24. Mehta NJ, Jani K, Khan IA. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am Heart J 2003; 145:821-825 (Pubitemid 36570952)
25. La Vecchia L, Ottani F, Favero L, et al. Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart 2004; 90:633-637 (Pubitemid 38668535)
26. Binder L, Pieske B, Olschewski M, et al. N-terminal probrain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112:1573-1579 (Pubitemid 41324518)
27. Scridon T, Scridon C, Skali H, et al. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96:303-305 (Pubitemid 40978593)
28. Douketis JD, Crowther MA, Stanton EB, et al. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch Intern Med 2002; 162:79-81 (Pubitemid 34073404)
29. Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000; 36:1632-1636 (Pubitemid 30826000)
30. Punukollu G, Khan IA, Gowda RM, et al. Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms. Int J Cardiol 2005; 99:207-211 (Pubitemid 40320791)
31. Masotti L, Antonelli F, Venturini E, et al. Cardiac troponin I and plasma D-dimer are related to proximal and bilateral extension of clots and right cardiac dysfunction in patients with pulmonary embolism. J Int Med 2007; 262:588-589 (Pubitemid 47620506)
32. Vuilleumier N, Righini M, Perrier A, et al. Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res 2008; 121:617-624 (Pubitemid 351305290)
33. Maziere F, Birolleau S, Medimagh S, et al. Comparison of troponin I and N-terminal-pro B-type natriuretic peptide for risk stratification in patients with pulmonary embolism. Eur J Emerg Med 2007; 14:207-211 (Pubitemid 47051935)
34. Aksay E, Yanturali S, Kiyan S. Can elevated troponin I levels predict complicated clinical course and inhospital mortality in patients with acute pulmonary embolism? Am J Emerg Med 2007; 25:138-143
35. Zhu L, Yang YH, Wu YF, et al. Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary thromboembolism. Chin Med J (Engl) 2007; 120:17-21 (Pubitemid 46117578)
36. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123:1947-1952 (Pubitemid 36706716)
37. Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based assessment model in acute pulmonary embolism. Eur Heart J 2005; 26:2166-2172 (Pubitemid 41408001)
38. Bova C, Crocco F, Ricchio R, et al. Importance of troponin T for the risk stratification of normotensive patients with pulmonary embolism: a prospective, cohort study with a three-month follow-up. Haematologica 2005; 90:423-424 (Pubitemid 40389004)
39. Douketis JD, Leeuwenkamp O, Grobara P, et al. The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism. J Thromb Haemost 2005; 3:508-513 (Pubitemid 41632876)
40. Kline JA, Hernandez-Nino J, Rose GA, et al. Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism. Crit Care Med 2006; 34:2773-2780 (Pubitemid 44610942)
41. Tulevski II, ten Wolde M, van Veldhuisen DJ, et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 2007; 116:161-166
42. Kucher N, Goldhaber S. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108:2191-2194 (Pubitemid 37363033)
43. Jiménez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient treatment. Chest 2007; 132:24-30 (Pubitemid 47068199)